Download PDF
Int J Angiol 2023; 32(04): 269-272
DOI: 10.1055/s-0041-1740103
Case Report

Left Atrial Myxoma and Antiphospholipid Syndrome—A Case Report

Mijo Meter
1   Department of Cardiology, University Hospital Centre Split, Split, Croatia
,
Diana Meter
2   Department of Rheumatology and Clinical Immunology, University Hospital Centre Split, Split, Croatia
,
Toni Ceprnja
3   Department of Pathology, Forensic Medicine and Cytology, University Hospital Centre Split, Split, Croatia
,
Dijana Perkovic
2   Department of Rheumatology and Clinical Immunology, University Hospital Centre Split, Split, Croatia
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Cardiac myxoma (CM) is the most frequent type of primary cardiac neoplasm and is responsible for 58 to 80% of primary cardiac tumors. The antiphospholipid syndrome (APS) occurs most commonly in the systemic lupus erythematosus but it can be also found in other conditions. The coexistence of CM and APS is rarely described in the literature. We report an unusual case of the left atrial myxoma and concomitant APS in a female patient who presented with right-sided hemiplegia. Although rare, we must think about the CM in patients with a newly diagnosed APS and left atrial mass. Nevertheless, we must make a distinction from other possible cardiac structures, especially atrial thrombus. Transthoracic echocardiography is the most frequently used initial imaging modality to detect CM. The aim of this case report was to emphasize that additional imaging modalities and multidisciplinary approach are mandatory in making a proper diagnosis and to choose a further treatment strategy.

Keywords

cardiac tumor - antiphospholipid syndrome - echocardiography - left atrial myxoma - thromboembolism - ischemia


Publication History

Article published online:
11 December 2021

© 2021. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 ElBardissi AW, Dearani JA, Daly RC. et al. Analysis of benign ventricular tumors: long-term outcome after resection. J Thorac Cardiovasc Surg 2008; 135 (05) 1061-1068
    CrossrefPubMedGoogle Scholar
  • 2 Tazelaar HD, Locke TJ, McGregor CG. Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc 1992; 67 (10) 957-965
    CrossrefPubMedGoogle Scholar
  • 3 Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001; 80 (03) 159-172
    CrossrefPubMedGoogle Scholar
  • 4 Roque A, Kimbrough T, Traner C. et al. Somatic PRKAR1A mutation in sporadic atrial myxoma with cerebral parenchymal metastases: a case report. J Med Case Reports 2019; 13 (01) 389
    CrossrefPubMedGoogle Scholar
  • 5 Tufano A, Di Minno MND, Guida A, Lembo M, Di Minno G, Galderisi M. Cardiac manifestations of antiphospholipid syndrome: clinical presentation, role of cardiac imaging, and treatment strategies. Semin Thromb Hemost 2019; 45 (05) 468-477
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Tenedios F, Erkan D, Lockshin MD. Cardiac involvement in the antiphospholipid syndrome. Lupus 2005; 14 (09) 691-696
    CrossrefPubMedGoogle Scholar
  • 7 Basso C, Valente M, Poletti A, Casarotto D, Thiene G. Surgical pathology of primary cardiac and pericardial tumors. Eur J Cardiothorac Surg 1997; 12 (05) 730-737 , discussion 737–738
    CrossrefPubMedGoogle Scholar
  • 8 Burke AP, Virmani R. Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 1993; 100 (06) 671-680
    CrossrefPubMedGoogle Scholar
  • 9 Cianciulli TF, Cozzarin A, Soumoulou JB. et al. Twenty years of clinical experience with cardiac myxomas: diagnosis, treatment, and follow up. J Cardiovasc Imaging 2019; 27 (01) 37-47
    CrossrefPubMedGoogle Scholar
  • 10 Scheffel H, Baumueller S, Stolzmann P. et al. Atrial myxomas and thrombi: comparison of imaging features on CT. AJR Am J Roentgenol 2009; 192 (03) 639-645
    CrossrefPubMedGoogle Scholar
  • 11 Reynen K. Cardiac myxomas. N Engl J Med 1995; 333 (24) 1610-1617
    CrossrefPubMedGoogle Scholar
  • 12 Oliveira R, Branco L, Galrinho A. et al. Cardiac myxoma: a 13-year experience in echocardiographic diagnosis. Rev Port Cardiol 2010; 29 (7-8) 1087-1100
    PubMedGoogle Scholar
  • 13 Knepper LE, Biller J, Adams Jr HP, Bruno A. Neurologic manifestations of atrial myxoma. A 12-year experience and review. Stroke 1988; 19 (11) 1435-1440
    CrossrefPubMedGoogle Scholar
  • 14 Colin GC, Dymarkowski S, Gerber B, Michoux N, Bogaert J. Cardiac myxoma imaging features and tissue characteristics at cardiovascular magnetic resonance. Int J Cardiol 2016; 202: 950-951
    CrossrefPubMedGoogle Scholar
  • 15 Kolitz T, Shiber S, Sharabi I, Winder A, Zandman-Goddard G. Cardiac manifestations of antiphospholipid syndrome with focus on its primary form. Front Immunol 2019; 10: 941
    CrossrefPubMedGoogle Scholar
  • 16 Miyakis S, Lockshin MD, Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (02) 295-306
    CrossrefPubMedGoogle Scholar
  • 17 Barbhaiya M, Erkan D. Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?. Curr Rheumatol Rep 2011; 13 (01) 59-69
    CrossrefPubMedGoogle Scholar
  • 18 Cervera R. Recent advances in antiphospholipid antibody-related valvulopathies. J Autoimmun 2000; 15 (02) 123-125
    CrossrefPubMedGoogle Scholar
  • 19 Cervera Miguel JI, Navarro Ibáñez V, Calabuig Muñoz E, Tordera Higón P, Montero Alonso M. Antiphospholipid syndrome. The use of transesophageal echocardiography. Med Interna 2003; 20 (10) 532-533
    PubMedGoogle Scholar
  • 20 Gertner E, Leatherman JW. Intracardiac mural thrombus mimicking atrial myxoma in the antiphospholipid syndrome. J Rheumatol 1992; 19 (08) 1293-1298
    PubMedGoogle Scholar
  • 21 Quintanilla S, Ferrer S, Bravo M. Myxoma and antiphospholipid antibody syndrome. Rev Med Chil 1998; 126 (06) 670-676
    PubMedGoogle Scholar
  • 22 Pliakos C, Alexiadou E, Metallidis S. et al. Right atrium myxoma coexisting with antiphospholipid syndrome: a case report. Cardiovasc Ultrasound 2009; 7: 47
    CrossrefPubMedGoogle Scholar
  • 23 Esteban E, Blanes A, Moreno MT, Cánovas SJ, Montero JA, Sotillo JF. Right atrial myxoma in a patient with antiphospholipid antibodies. Rev Esp Cardiol 2002; 55 (09) 999-1002
    PubMedGoogle Scholar
  • 24 Wen XY, Chen YM, Yu LL. et al. Neurological manifestations of atrial myxoma: a retrospective analysis. Oncol Lett 2018; 16 (04) 4635-4639
    PubMedGoogle Scholar
  • 25 Cao GF, Bi Q, Cao L, Wang C. The clinical characteristics of stroke in young patients with cardiac myxoma. Zhonghua Nei Ke Za Zhi 2017; 56 (04) 263-267
    PubMedGoogle Scholar
  • 26 Riedl J, Pabinger I, Ay C. Platelets in cancer and thrombosis. Hamostaseologie 2014; 34 (01) 54-62
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Obrenović-Kirćanski B, Mikić A, Parapid B. et al. A 30-year-single-center experience in atrial myxomas: from presentation to treatment and prognosis. Thorac Cardiovasc Surg 2013; 61 (06) 530-536
    PubMedGoogle Scholar
  • 28 Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of antiphospholipid syndrome. Ann Rheum Dis 2019; 78 (02) 155-161
    CrossrefPubMedGoogle Scholar